Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -97.6% | -98.7% | 0 / 3 | -62.6% | -1.57 pp | -2.26 pp | +1.6% | 0.26 | 63.15 | 146 | −62,6% | 3,8 | −80,1% | 63.15 | 4.12 | +1.432,7% |
| Pts | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 12.300 (close price on 2026-10-14)EPS (TTM): 194,8
Financial charts
1.Revenue & growth
VND bn146Q2/26
1.Revenue & growth
VND bn146Q2/26
2.Profit & growth
VND bn3,76Q2/26
3.Profit mix (Penman)
VND bn9,41Q2/26
4.Margins & cost structure
%10.6%Q2/26
5.Returns & cash cycle
This company reports nothing on these lines.
6.Earnings quality & cash
VND bn297Q2/26
7.Asset structure
VND bn538Q2/26
8.Funding & debt health
VND bn · times538Q2/26
9.Revenue backlog
VND bn6,93Q2/26
10.Valuation
times · %65,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %107Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26